CPT1B and breast carcinoma: Carnitine palmitoyltransferase 1B (CPT1B) exerts rate-controlling-enzyme roles in fatty acids β-oxidation, could be inhibited by inhibiting JAK/STAT3 promoting breast cancer cells to re-sensitize to chemotherapy [50].